Technology | 2018.10.04
Adagio Medical Completes Chronic Pre-Clinical Atrial Fibrillation Study Using Ultra-Low Temperature Cryoablation Technology
LAGUNA HILLS, Calif., Oct. 4, 2018 /PRNewswire/ -- Adagio Medical, Inc., the developer of the iCLAS™ technology, the company\'s ultra-low temperature intelligent continuous lesion ablation system for the treatment of cardiac arrhythmias, announces the successful completion of its chronic...
For more information, please visit
https://www.prnewswire.com:443/news-rele[...]tion-technology-300724330.html
